Abstract:OBJECTIVE:To evaluate retrospectively the feasibility, efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) or percutaneous transhepatic or transsplenic approach to the portal vein with the combination of TIPS for the treatment of patients with portal vein thrombosis with or without cavernous transformation.METHODS:Sixty-five patients with portal vein thrombosis from July 2002 to August 2007 at our hospital were analyzed retrospectively. Indirect portography through superior mesenteric artery was performed to determine the approaches for TIPS procedure. If the intrahepatic portal vein branches were visualized, TIPS was implemented directly from transjugular approach; if the intrahepatic portal vein branches failed to be visualized, an ultrasound-guided percutaneous transhepatic or transsplenic approach was performed to recanalize the thrombosed portal vein initially followed by TIPS placement to reconstruct the portal venous flow. Efficacy and complications were observed and revision and survival rates monitored during the follow-up.RESULTS:TIPS were successfully created in 54 of 65 patients with portal vein thrombosis with a success rate of 83.1%. Among them, TIPS were performed directly in 36 of 40 patients; portal vein recanalization were successfully performed via transhepatic access in 15 of 25 patients, and 3 of remaining 5 who failed the transhepatic approach were successfully done from transsplenic access. Then TIPS placement was accomplished with a success rate of 72.0% (18/25). The success rate in cirrhotic patients was 82.4% (42/51) and it was not significant different from those without cirrhosis 85.7% (12/14) (P = 0.766). While the success rate in the patients with cavernous transformation 71.8% (28/39) showed a significant difference compared to that without cavernous transformation 100% (26/26) (P = 0.002). The success rates in portal vein thrombosis and cavernous transformation with or without cirrhosis were 42.9% (18/42) and 83.3% (10/12) respectively, exhibiting a significant difference (P = 0.021). The mortality rate of 30 days post-operation was 3.7% (2/54). From Day 1 to 63 months follow-up, The incidence rate of hepatic encephalopathy was 27.8% (15/54); revision rate 22.2% (12/54); median survival time 31.4 months.CONCLUSIONS:Conventional TIPS or percutaneous transhepatic or transsplenic approach combined with TIPS for the treatment of portal vein thrombosis with or without cavernous transformation are feasible, safe and effective. It is essential to recanalize the thrombosed portal vein initially followed by TIPS placement to reconstruct the portal venous flow.

Use of an Intrahepatic Arterial Targeting Wire for Guiding Portal Vein Puncture During TIPS Creation in Patients with Obliterative Portal Vein Thrombosis

Intrahepatic Arterial Localizer Guided Transjugular Intrahepatic Portosystemic Shunt Placement

Intrahepatic arterial localizer guided transjugular intrahepatic portosystemic shunt placement: Feasibility, efficacy, and technical success assessed by a case series-a STROBE- compliant article.

Elective Transjugular Intrahepatic Portosystemic Shunt Using Viatorr Stent-Grafts: A Single-Center Experience from China

A New Alternative Technique for the Guidance of Transjugular Intrahepatic Portosystemic Shunt Creation Using DSA Overlay Reference

[Transjugular Intrahepatic Portosystemic Shunt and Combination with Percutaneous Transhepatic or Transsplenic Approach for the Treatment of Portal Vein Thrombosis with or Without Cavernomatous Transformation].

[Clinical study of transjugular intrahepatic portosystemic shunt with Viatorr stent in 43 cases]

Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombus-Related Symptomatic Portal Hypertension

CBCT-based Three-Dimensional Dual-Phase Vascular Image Fusion: a Novel Technique for Interventional Real-Time TIPS Guidance

Clinical efficacy of interventional therapy via TIPS approach for the treatment of acute or subacute portal venous thrombosis

Status of transjugular intrahepatic portosystemic shunt for portal hypertension in China: A national survey analysis

Effect of transjugular intrahepatic portosystemic shunt in treatment of chronic portal vein thrombosis with esophageal variceal bleeding

Role of transjugular intrahepatic portosystemic shunt in the control of variceal bleeding and ascites due to portal hypertension

Double C-Arm Digital Subtraction Angiography Guidance During Transjugular Intrahepatic Portosystemic Shunt Placement

Covered TIPS Procedure-Related Major Complications: Incidence, Management and Outcome From a Single Center

3D C-Arm cone beam CT for targeting the portal vein during TIPS: Initial clinical experience

Is Post-TIPS Anticoagulation Therapy Necessary in Patients with Cirrhosis and Portal Vein Thrombosis? A Randomized Controlled Trial

Feasibility of Augmented Reality–Guided Transjugular Intrahepatic Portosystemic Shunt

Comparison of Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Cirrhosis With or Without Portal Vein Thrombosis: A Retrospective Study

Endovascular treatment for nonacute symptomatic portal venous thrombosis through intrahepatic portosystemic shunt approach.

[Intrahepatic Portosystemic Shunt Assisted by Percutaneous Transhepatic Approach for Treatment of Portal Vein Thrombosis].